-
Research HighlightJanuary 27, 2023Improving iPSC research with new cell lines
A stable iPSC line, KOLF2.1J, has been established to act as a high-quality baseline platform for modeling human disease. -
Research HighlightDecember 20, 2022Revealing the biology of senescent cells
JAX is playing a major role to bridge experimental mouse and human data and reveal the biology of senescent cells. -
Featured ArticleNovember 22, 2022Understanding cancer-causing MYC and its alternative splicing accomplices
Humans have about 20,000 genes (give or take), far fewer genes than many so-called “primitive” animals, like Daphina pulex, a.k.a. the water flea, which has about 31,000. How then are humans able to be so complex with less genetic material? One answer: alternative splicing. -
Featured ArticleOctober 13, 2022Retraining the immune system to fight against cancer
With a new tactic in immunotherapy, Derya Unutmaz and his team has successfully engineered an atypical type of immune cell, the human mucosal-associated T cell, with the capabilities to overcome challenges in standard CAR-T cell treatment.
-
Press ReleaseJanuary 24, 2023Jennifer Trowbridge receives award from The Mark Foundation for Cancer Research
Trowbridge has been recognized as an outstanding early-career scientist and will receive a $750,000 award. -
Featured ArticleDecember 01, 2022Brooks Scholar Award propels cancer and aging research
Recipients of the 2022 Brooks Scholar Award represent a new generation of scientists whose research bridges the fields of cancer and aging. -
Press ReleaseOctober 24, 2022JAX participates in A Day of Hope for Maines cancer fighters
Eight team members who make up JAX's MCGI recently attended MaineGeneral's annual Day of Hope Event at the Augusta Civic Center. -
Research HighlightOctober 06, 2022Improving preclinical cancer research with diverse mouse strains
Muneer Hasham leads a team that is facilitating research into cancer biology and tumor microenvironments in the context of genetic diversity.